The findings could lead to ablood testfor lung cancer, according to a researcher with the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute who helped lead study. "We found patterns of abnormal microRNAs in the plasma o...
The use of low-dose CT (LDCT) as a screening tool for lung cancer hasbeen criticizedfor its high cost and its feasibility, given the large number of long-time heavy smokers and ex-smokers and the complexity of the process. What if a less expensive and more easily administered test could ...
“These findings suggest that lung cancers interact with circulating white blood cells and change the types of genes that are active in these cells. This finding can be potentially used to develop a non-invasive diagnostic test for patients suspected of having lung cancer,” said Dr. Vachani. ...
We recently identified a serum microRNA signature (the miR-Test) that could identify the optimal target population. Here, we performed a large-scale validation study of the miR-Test in high-risk individuals (n = 1115) enrolled in the Continuous Observation of Smoking Subjects (COSMOS) lung ...
“if we had an easy-to-implement clinical tool, like a blood test, that captured someone’s lung function trajectory at a single time point, it would enable earlier interventions which might, in the long run, improve lung health,” kalhan added. chronic obstructive pulmonary dis...
"This is coming, and it's coming fast," said Dr. David Gandara, a lung specialist at the University of California, Davis, who had no role in the studies but consults for two companies developing liquid biopsies. A test that could spare many people unnecessary treatment "would be huge,"...
■ Lung ■ Intestine ■ Kidney ■ Fat ■ Blood vessels (arteries) ■ Immune tissue ■ Muscle ■ Pancreas The blood test looks for levels of thousands of proteins to give clues on which organs are ageing at different rates. The pattern of proteins detected appeared to be specific to particula...
What Should You Know About Blood Tests for Breast Cancer? Every year, more than 200,000 women in the U.S. are told they have breast cancer. On the upside, deaths from the disease are declining as research and advances in diagnosis and treatment continue. ...
test may help to identify those possibly at risk for lung cancer death,” said co-corresponding author Edwin Ostrin, MD, PhD, assistant professor of general internal medicine. “We envision this as a tool that could be deployed worldwide, as the future of early detection of this disea...
A new study led by researchers at the Stanford University School of Medicine indicates that profiling the genes of lung-tumor cells from patient blood samples may be a cheap, noninvasive way to help doctors choose the right treatments.